Physician

Richard K Rosenberg, M.D.

According to 2025 Medicare claims, Richard Rosenberg, M.D. (NPI: 1215976816) practices hematology/oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is TMC MEDICAL NETWORK (NPI: 1750832283; TIN: 811156192) and primary practice location at 85622-1915. Rosenberg is affiliated with the ABC Network (ACO ID: A5554), participating under the MSSP model.

Rosenberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 625 traditional Medicare patients, billed 130,775 HCPCS/CPT codes, and received $2,111,432 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,288 prescription claims across 278 beneficiaries totaling $4,489,501 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 52 claims. Open Payments data shows 45 records totaling $35,076. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,950,442 and ending at $2,111,432. Concurrently, Part D prescription costs have risen steadily, from $1,128,859 to $4,489,501. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	816	158,745	$1,950,442
2016	912	191,497	$2,550,888
2017	985	85,934	$1,602,315
2018	962	160,132	$2,534,427
2019	975	245,960	$3,223,159
2020	877	228,905	$3,299,383
2021	756	131,079	$1,973,405
2022	579	103,971	$1,506,775
2023	470	61,497	$1,069,020
2024	625	130,775	$2,111,432

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	164	769	$1,128,859
2016	160	900	$1,981,942
2017	154	711	$1,428,240
2018	184	767	$1,263,200
2019	213	775	$2,534,581
2020	224	863	$1,905,398
2021	215	891	$1,533,600
2022	217	803	$1,811,581
2023	193	1,004	$2,503,492
2024	278	1,288	$4,489,501

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	77	$65,712
2016	N/R	135	$87,040
2017	N/R	95	$59,661
2018	N/R	97	$71,014
2019	N/R	68	$45,456
2020	N/R	34	$3,681
2021	N/R	79	$10,420
2022	N/R	88	$51,829
2023	N/R	32	$5,791
2024	N/R	52	$43,371

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	208	438	$137
96413	Administration of chemotherapy into vein, 1 hour or less	116	343	$98
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	158	479	$25
96375	Injection of additional new drug or substance into vein	86	541	$12
96372	Injection of drug or substance under skin or into muscle	109	195	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	97	2,548	$1,140,060
Revlimid	Lenalidomide	39	1,008	$629,115
Pomalyst	Pomalidomide	18	504	$410,625
Brukinsa	Zanubrutinib	24	720	$338,501
Imbruvica	Ibrutinib	22	642	$304,659

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1576	Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$37,601
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	13	$4,285
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	14	$996
E1392	Portable oxygen concentrator, rental	Y	N/R	13	$489

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$602	Celgene Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	19	$34,474	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard K. Rosenberg, M.D.?

Tedicare shows public-source Medicare data for Richard K. Rosenberg, M.D. (NPI 1215976816), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard K. Rosenberg, M.D. have ACO affiliation data?

Richard K. Rosenberg, M.D. is shown with ACO affiliation data for ABC Network (MSSP, ACO ID A5554).

What billing organization is linked to Richard K. Rosenberg, M.D.?

Richard K. Rosenberg, M.D. is linked to TMC MEDICAL NETWORK (billing NPI 1750832283) in the available physician profile data.

Does Richard K. Rosenberg, M.D. have Open Payments data?

Richard K. Rosenberg, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.